130 related articles for article (PubMed ID: 11150711)
1. Synthesis and evaluation of the (99m)tc-complexes of L-cysteine acetyldiglycine (a hybrid of MAG3 and L,L-EC) and of L-beta-homocysteine acetyldiglycine.
Mang'era K; Vanbilloen H; Cleynhens B; de Groot T ; Bormans G; Verbruggen A; Verbeke K
Nucl Med Biol; 2000 Nov; 27(8):781-9. PubMed ID: 11150711
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 99mTc-mercaptoacetyltripeptides in mice and a baboon.
Bormans G; Cleynhens B; Hoogmartens M; de Roo M; VerBruggen A
Int J Rad Appl Instrum B; 1992 Apr; 19(3):375-88. PubMed ID: 1385802
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
[TBL] [Abstract][Full Text] [Related]
6. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
7. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution.
Jeong JM; Kinuya S; Paik CH; Saga T; Sood VK; Carrasquillo JA; Neumann RD; Reynolds JC
Nucl Med Biol; 1994 Oct; 21(7):935-40. PubMed ID: 9234347
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
[TBL] [Abstract][Full Text] [Related]
9. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.
Kim DW; Kim WH; Kim MH; Kim CG
Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963
[TBL] [Abstract][Full Text] [Related]
12. NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.
Chang F; Qu T; Rusckowski M; Hnatowich DJ
Appl Radiat Isot; 1999 Apr; 50(4):723-32. PubMed ID: 10101833
[TBL] [Abstract][Full Text] [Related]
13. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
14. Development of a conjugate of (99m)Tc-EC with aminomethylenediphosphonate in the search for a bone tracer with fast clearance from soft tissue.
Verbeke K; Rozenski J; Cleynhens B; Vanbilloen H; de Groot T; Weyns N; Bormans G; Verbruggen A
Bioconjug Chem; 2002; 13(1):16-22. PubMed ID: 11792174
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging.
Lu X; Zhao L; Xue T; Zhang H
J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042
[TBL] [Abstract][Full Text] [Related]
17. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.
Vanbilloen HP; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1996 Jan; 23(1):40-8. PubMed ID: 8586100
[TBL] [Abstract][Full Text] [Related]
18. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
[TBL] [Abstract][Full Text] [Related]
19. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
Liu S; Hsieh WY; Kim YS; Mohammed SI
Bioconjug Chem; 2005; 16(6):1580-8. PubMed ID: 16287258
[TBL] [Abstract][Full Text] [Related]
20. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.
He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT
Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
